By c.angulo, 14 September, 2018 IGDRP - 2nd International Generic Drug Regulators Programme - Biowaivers Working Group - Public statement The Biowaivers Working Group held a face to face meeting on 2-3 November 2015 as part of the 2nd meeting of the International Generic Drug Regulators
By c.angulo, 14 September, 2018 IGDRP - 1st International Generic Drug Regulators Programme - Biowaivers Working Group - Public statement The IGDRP Biowaivers working group was formed in May 2013 with the objective of establishing a common set of conditions for the granting of biowaivers
By c.angulo, 14 September, 2018 IGDRP - 2nd International Generic Drug Regulators Programme – Active Substance Master File (ASMF)/Drug Master File (DMF) Working Group - Public statement With a view to improving international cooperation and work-sharing in the assessment of ASMF/DMF for generic drugs, the members of the ASMF/DMF Worki
By c.angulo, 14 September, 2018 IGDRP - 1st International Generic Drug Regulators Programme - ASMF/DMF Working Group - Public statement The IGDRP ASMF/DMF working group was formed in May 2013 to foster international collaboration and worksharing in the area of evaluations for ASMFs/DMF